Computer simulations of disease processes and detailed digital models of our organs could provide more accurate monitoring and outcome measurements for clinical trials. The research being presented at the University of Sheffield in the UK on
Thursday aims to develop a model of pulmonary arterial hypertension using MRI technology.
“Two-thirds of the patients we assessed could be correctly diagnosed with PAH using our model, which meant only those patients, where diagnosis was unclear, would have had to have the catheter test if this was in full clinical use,” said Andy Swift, Insigneo Senior Clinical Research fellow.
Currently, the condition is diagnosed by inserting a catheter into the patient, often in the neck or groin to test the pressure in the pulmonary artery.